FindMyKOL
Clinical trialNCT01301586UnknownPhase 1/PHASE2Interventional

A Novel Combination Oral Agent to Treat Acne Vulgaris

SponsorNexgen Dermatologics, Inc.Enrollment60ACNE VULGARIS
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Palos Verdes Dermatology Associates

    Rolling Hills Estates, California, United States

    HOWARD FEIN, MD
    Recruiting
  • Berlin Center

    Boynton Beach, Florida, United States

    Joshua M Berlin, MD →
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Doxycycline →Doxycycline and S-equol
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2010
Primary completion
30 Sept 2011
Completion
30 Sept 2011
Last update posted
23 Feb 2011
Registered enrollment
60
Registry id
NCT01301586
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.